Designer immune-cell therapy could shrink deadly brain tumors, early trials show

By KASPERA 0 Min Read

Two early clinical trials that together included nine patients suggest that a treatment called CAR-T therapy could treat glioblastoma, but its long-term effects are unknown. …read more

Source:: Live Science

Share This Article
Leave a comment